-
Sisters of jailed Pakistan ex-PM Imran Khan arrested
-
The Haupt Collection: What Money Reveals About Us as Human Beings
-
African players in Europe: Semenyo brace helps City top table
-
Barcelona enter new era aiming to retain Women's Champions League crown
-
'For my family': India boxer beats hardship, injury to go for Games gold
-
US has deported 25,000 to third countries under secretive deals: report
-
Indonesia doing 'everything' but still struggling to curb fires
-
Three South Korean soldiers injured in DMZ blast: military
-
Once decried as 'human cockfighting', MMA wants Olympic spot
-
New Zealanders pick endangered black robin as Bird of the Year
-
China's Yu, 13, great for swimming says multiple Olympic medallist
-
Asia stocks rise on AI, US-China trade talks optimism
-
Putin's party set to retain power after Russia vote hit by cyberattacks, drones
-
Malaysia's 'elephant whisperer' fights to save Borneo's endangered giants
-
Germany's Merz under pressure after bruising state election losses
-
'I live in fear': 1.5 million Pakistani children sexually exploited online
-
Messi, Miami frustrated in 2-2 draw with San Diego
-
Cowboys beat Commanders, Vikings down Bears as star QBs injured
-
Thousands march in France against 'licence to kill' draft law
-
4 Hacks for Yearlong Savings on Your Kids' Wardrobes
-
Guardian Metal Resources PLC Announces Positive Tempiute Tungsten Drilling Results
-
Best Gold IRA Accounts 2026 Rankings Released: Top Precious Metals IRA Companies Compared in New Guide
-
Crexendo Expands AI Portfolio Through Meetric Partnership, Adding Omnichannel Conversation Intelligence for More Than 250 Platform Licensees
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 21
-
EB5 United's Cormont at Deer Valley East Village Achieves $224.8 Million Target EB-5 Raise; Offering Remains Open Toward $524.8 Million Maximum Raise
-
Braves clinch division title as Red Sox reach MLB playoffs
-
Forest fire threatens tourist town in Colombian Andes
-
Bordeaux-Begles hammer Stade Francais despite Jalibert injury
-
Torres on target again as PSG beat 10-man Marseille in Ligue 1
-
Milan and Juventus end blips with home wins
-
Germany's Merz vows to stay course despite new election defeats
-
Bridgeman wins PGA Biltmore title with sizzling 61
-
Carrick demands Man Utd response after 'pathetic' jibes
-
Williams injured as Bears shut down by Vikings
-
Liverpool boss Iraola urges Isak to raise his level
-
US warns of rapid escalation in Middle East war
-
Evenepoel wins record 4th straight world time-trial title
-
Germany's far-right AfD celebrates another state election win
-
France's Macron, Canada's Carney announce closer ties
-
Russia vows revenge for election-day attacks as poll shows ruling party win
-
Carrick defends troubled Man Utd after Fulham escape
-
Spaun late shows snatches PGA Championship win
-
Horror movie 'Resident Evil' tops N. American box office
-
Conceicao strikes as Juventus beat Atalanta
-
Germany's Merz vows to stay course despite new vote losses
-
Britain, Zverev-inspired Germany, Spain complete Davis Cup finals
-
Man City outgun Sunderland despite Brobbey hat-trick, Man Utd rescue Fulham draw
-
Man Utd salvage Fulham draw as pressure mounts on Carrick
-
Mourinho blames ref committee for Real Madrid derby defeat
-
Spanish civil war drama 'The Black Ball' wins at Toronto festival
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
H.Romero--AT